• Citer

Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.

par Deltenre, Pierre ;Moreno, Christophe ;Tran, Annelise;Ollivier, I;Provôt, F;Stanke, F;Lazrek, Mouna;Castel, Hélène;Canva, Valérie;Louvet, Alexandre;Colin, Michel ;Glowacki, François;Dharancy, Sébastien;Henrion, Jean;Hazzan, Marc;Noel, Christian;Mathurin, Philippe
Référence Alimentary pharmacology & therapeutics, 34, 4, page (454-461)
Publication Publié, 2011-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
Auteur:	Deltenre, Pierre; Moreno, Christophe; Tran, Annelise; Ollivier, I; Provôt, F; Stanke, F; Lazrek, Mouna; Castel, Hélène; Canva, Valérie; Louvet, Alexandre; Colin, Michel; Glowacki, François; Dharancy, Sébastien; Henrion, Jean; Hazzan, Marc; Noel, Christian; Mathurin, Philippe
Informations sur la publication:	Alimentary pharmacology & therapeutics, 34, 4, page (454-461)
Statut de publication:	Publié, 2011-08
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Antiviral Agents -- administration & dosage -- adverse effects
	Dose-Response Relationship, Drug
	Drug Therapy, Combination
	Female
	Follow-Up Studies
	Hepatitis C, Chronic -- drug therapy
	Humans
	Interferon-alpha -- administration & dosage -- adverse effects
	Kidney Failure, Chronic -- therapy
	Kidney Transplantation
	Male
	Middle Aged
	Polyethylene Glycols -- administration & dosage -- adverse effects
	Recombinant Proteins
	Renal Dialysis
	Ribavirin -- administration & dosage -- adverse effects
	Time Factors
	Treatment Outcome
	Viral Load
Note générale:	Journal Article
	FLWIN
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0269-2813
	info:doi/10.1111/j.1365-2036.2011.04741.x
	info:scp/79960559742
	info:pmid/21682756